Governments should pay for smoking cessation therapies: Canadian researchers

Aug 30, 2010

Canada should follow the lead of Quebec, Australia and the United Kingdom by publicly funding smoking cessation pharmacotherapies, states an editorial in CMAJ (Canadian Medical Association Journal).

Some 5.5 million Canadians (19% of the population) currently use tobacco, a number that has not decreased in recent years. A 2009 review of studies indicates that full financial reimbursement of smoking cessation medications significantly improves one-year abstinence rates among all smokers. And those who quit live, on average, an additional four years. Fully funding these tools in Canada could result in a gain of 1.9 million life-years, at a cost of $220 for every life-year gained, which is a bargain compared with other health interventions.

Currently, only Quebec publicly funds all smoking cessation pharmacotherapies, and only the Yukon and Prince Edward Island reimburse for at least one product. In Australia and the United Kingdom reimbursement is available without restriction for all products, including prescription medications and over-the-counter . In the United States, these products are reimbursed by Veterans Affairs and Part D Medicare.

The editorial writers propose immediately including smoking cessation therapies in all provincial drug formularies so that smokers over the age of 65 and those receiving social assistance can have free access. Then "follow the lead of other countries and reimburse therapies for everyone," write Erika D. Penz and Braden J. Manns of the University of Calgary, Dr. Matthew B. Stanbrook, Deputy Editor Scientific and Dr. Paul Hebert, Editor-in-Chief. "An appropriate source of funding for this is obvious: the substantial tax revenues collected with the sale of every tobacco product."

Explore further: Planning for the move from children's to adult palliative care

More information: www.cmaj.ca/cgi/doi/10.1503/cmaj.101140

add to favorites email to friend print save as pdf

Related Stories

Smoking cessation therapies more effective than placebos

Jul 14, 2008

Six treatments for smoking cessation perform better than placebos — including varenicline (Chantix®), recently approved for use in Canada — states a team of researchers from McGill University and the University of Montreal ...

Not ready to quit? Try cutting back

Dec 07, 2006

In a review article in the December Nicotine and Tobacco Research, researchers at the University of Vermont have found an unexpected, effective alternative to motivate smokers to quit smoking – cutting back. According to ...

Recommended for you

Planning for the move from children's to adult palliative care

17 minutes ago

The differences between children's and adult palliative care services are too wide for young people with life-limiting conditions to negotiate, according to research by Bangor University. Commenting on the findings, the researchers ...

Improving clinical pain management practices

57 minutes ago

Oncologists treat cancer, neurologists specialise in brain disorders, immunologists diagnose infectious diseases, and a host of other specialists tackle ailments from broken bones to ruptured arteries. But ...

Train your brain to prefer healthy foods

1 hour ago

"I can resist anything except temptation." Anyone who has ever been on a diet can relate to that quip from Oscar Wilde. No matter what the fad diet du jour says, the only way to lose weight is to reduce the net number of ...

User comments : 0